ANVS
#4091
Annovis Bio, Inc. Common Stock
1.6 9 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.87%
Variación mensual
-4.52%
Variación en los últimos 6 meses
-32.40%
Cambio anual
-26.84%
Cierres anteriores
1.7 4
Open
1.6 9
Mínimo
1.6 7
Máximo
1.7 0
Volumen
65
Financials
- Market Capitalization 72 M
- Employee 7
- Founded 2008
- CEO Maria-luisa Maccecchini
- Website www.annovisbio.com
- Headquarter Delaware, United States
- FIGI BBG00PN9XD40
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4070 |  CING Cingulate Inc. - Common Stock | 5.14 USD | -0.58% | -10.92% | +5.54% | -16.56% | 74.74 M USD | ||
| 4074 |  NRXS Neuraxis, Inc. Common Stock | 5.91 USD | -1.34% | -3.90% | -8.09% | +8.84% | 74.22 M USD | ||
| 4098 |  MNOV MediciNova, Inc. - Common Stock | 1.45 USD | +0.69% | -7.64% | +9.85% | +11.54% | 71.37 M USD | ||
| 4105 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.20 USD | -1.64% | -3.23% | +1.69% | -41.18% | 69.88 M USD |